PharmaBlock Sciences (Nanjing), Inc.
SZSE:300725.SZ
39.57 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 290.201 | 511.186 | 1,150.43 | 699.627 | 1,244.806 | 163.576 | 265.777 | 157.562 | 78.053 | 61.177 | 13.865 | 19.406 |
| Short Term Investments
| 465.607 | 1,089.614 | 163.295 | 304.428 | 107.625 | 21.52 | -3.629 | -4.771 | -2.227 | -0 | 2 | 0 |
| Cash and Short Term Investments
| 755.807 | 1,600.799 | 1,313.725 | 1,004.055 | 1,352.43 | 185.096 | 265.777 | 157.562 | 78.053 | 61.177 | 15.865 | 19.406 |
| Net Receivables
| 485.605 | 476.282 | 330.609 | 201.273 | 167.082 | 79.494 | 35.2 | 0 | 27.301 | 19.582 | 9.903 | 6.22 |
| Inventory
| 840.165 | 724.788 | 676.391 | 447.942 | 309.63 | 206.916 | 144.261 | 116.943 | 77.21 | 42.97 | 30.595 | 19.356 |
| Other Current Assets
| 635.361 | 15.881 | 339.087 | 150.738 | 44.077 | 65.005 | 63.443 | 110.08 | 8.143 | 8.774 | 11.495 | 10.916 |
| Total Current Assets
| 2,716.938 | 2,817.75 | 2,659.812 | 1,804.008 | 1,873.219 | 536.511 | 509.131 | 430.993 | 190.708 | 132.503 | 67.859 | 55.898 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,684.181 | 1,753.345 | 1,661.273 | 1,173.272 | 309.357 | 257.688 | 125.882 | 93.041 | 74.982 | 30.467 | 28.289 | 23.875 |
| Goodwill
| 355.742 | 356.186 | 356.186 | 356.186 | 31.203 | 31.203 | 6.901 | 6.457 | 6.457 | 0 | 0 | 0 |
| Intangible Assets
| 107.984 | 109.417 | 111.479 | 111.468 | 33.826 | 25.119 | 24.095 | 19.979 | 9.514 | 1.935 | 2.009 | 2.066 |
| Goodwill and Intangible Assets
| 463.726 | 465.602 | 467.664 | 467.654 | 65.03 | 56.322 | 30.996 | 26.436 | 15.971 | 1.935 | 2.009 | 2.066 |
| Long Term Investments
| -445.745 | 5.483 | -157.636 | -295.519 | 49.347 | 131.939 | 84.781 | 5.964 | 3.42 | 2.338 | 0.216 | 2.216 |
| Tax Assets
| 32.629 | 38.609 | 35.798 | 15.096 | 11.658 | 4.277 | 4.293 | 3.691 | 2.789 | 0.867 | 0.465 | 0.276 |
| Other Non-Current Assets
| 483.543 | 23.244 | 195.277 | 342.412 | 116.679 | 42.401 | 6.078 | 7.27 | 11.278 | 4.371 | 2.719 | 0.795 |
| Total Non-Current Assets
| 2,218.334 | 2,286.283 | 2,202.377 | 1,702.915 | 552.071 | 492.627 | 252.03 | 136.402 | 108.441 | 39.978 | 33.699 | 29.229 |
| Total Assets
| 4,935.273 | 5,104.032 | 4,862.189 | 3,506.922 | 2,425.29 | 1,029.138 | 761.161 | 567.396 | 299.149 | 172.48 | 101.558 | 85.126 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 292.204 | 193.405 | 413.471 | 134.293 | 183.684 | 125.478 | 29.012 | 19.356 | 14.307 | 6.995 | 3.112 | 4.063 |
| Short Term Debt
| 230.268 | 609.917 | 163.403 | 399.841 | 120.435 | 60.36 | 25.223 | 0.299 | 3.8 | 0 | 0 | 0 |
| Tax Payables
| 27.196 | 15.7 | 10.396 | 6.441 | 13.657 | 8.679 | 11.187 | 3.136 | 6.299 | 4.644 | 4.175 | 3.874 |
| Deferred Revenue
| 0 | 0 | 39.633 | 161.895 | 169.181 | 83.069 | 11.187 | 23.835 | 15.458 | 0 | 0 | 0 |
| Other Current Liabilities
| 199.566 | 237.07 | 112.275 | 262.042 | 100.838 | 83.634 | 76.289 | 31.722 | 15.081 | 14.077 | 6.889 | 6.832 |
| Total Current Liabilities
| 749.234 | 1,056.092 | 739.178 | 788.883 | 475.939 | 278.151 | 152.899 | 54.514 | 39.486 | 25.717 | 14.176 | 14.77 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 1,129.74 | 1,138.713 | 1,392.373 | 23.604 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 45.714 | 51.737 | 52.4 | 53.691 | 53.633 | 9.062 | 7.419 | 7.321 | 3.413 | 0.2 | 0.2 | 0.2 |
| Deferred Tax Liabilities Non-Current
| 22.132 | 24.312 | 20.152 | 12.581 | 0.997 | 1.055 | 1.114 | 1.966 | 2.1 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.9 | 0.9 | 0.45 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 1,198.486 | 1,215.663 | 1,465.375 | 90.325 | 54.63 | 10.117 | 8.533 | 9.287 | 5.512 | 0.2 | 0.2 | 0.2 |
| Total Liabilities
| 1,947.72 | 2,271.755 | 2,204.553 | 879.208 | 530.569 | 288.268 | 161.432 | 63.801 | 44.999 | 25.917 | 14.376 | 14.97 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.141 | 0.227 | 0.033 | 0.102 |
| Common Stock
| 199.729 | 199.665 | 199.664 | 199.7 | 153.615 | 144.79 | 110 | 73.333 | 55 | 50 | 42.479 | 42.479 |
| Retained Earnings
| 1,496.827 | 1,338.924 | 1,164.367 | 892.831 | 444.404 | 297.528 | 179.941 | 74.996 | 13.89 | -18.643 | 32.356 | 18.7 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 389.488 | 369.408 | 161.558 | 77.281 | 25.021 | 41.767 | 42.238 | -1.141 | -0.227 | -0.033 | -0.102 |
| Other Total Stockholders Equity
| 1,290.997 | 904.2 | 1,293.605 | 1,338.335 | 1,296.701 | 298.549 | 268.021 | 304.688 | 173.969 | 114.341 | 12.202 | 2.898 |
| Total Shareholders Equity
| 2,987.553 | 2,832.277 | 2,657.636 | 2,427.425 | 1,894.72 | 740.867 | 599.73 | 495.255 | 245.301 | 145.698 | 87.037 | 69.997 |
| Total Equity
| 2,987.553 | 2,832.277 | 2,657.636 | 2,627.714 | 1,894.721 | 740.87 | 599.73 | 503.594 | 254.15 | 146.563 | 87.183 | 70.157 |
| Total Liabilities & Shareholders Equity
| 4,935.273 | 5,104.032 | 4,862.189 | 3,506.922 | 2,425.29 | 1,029.138 | 761.161 | 567.396 | 299.149 | 172.48 | 101.558 | 85.126 |